A Multicenter Prospective Study Evaluating Outcomes of Endoscopic Eradication Therapy in Patients With Barrett's Esophagus Associated Neoplasia: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium

Summary

A prospective outcomes study in patients with and esophageal cancer (EAC) and Barrett's esophagus (BE) associated neoplasia being evaluated for endoscopic eradication therapy (EET).

Description

Eligibility

Age range

18–100 years

Sex

All

Healthy volunteers

Yes

Interventions

• Procedure
  Endoscopic eradication therapies (EET)

  Endoscopic eradication therapies (EET) includes endoscopic mucosal resection (EMR), which describes the process by which the area most likely to harbor highest grade of dysplasia/neoplasia is removed; radiofrequency ablation (RFA), which describes the process by which Barrett's segments are removed via burning/ablation; and cryotherapy.

• Procedure
  Esophagectomy

  The esophagus is surgically removed

• Drug
  Chemotherapy

  Chemical substances are used to treat cancer

• Radiation
  Radiation

  Cancer cells are destroyed by radiation therapy.

Locations (4)